Drug Shortage Report for SOLYSTAT
Report ID | 5416 |
Drug Identification Number | 00769541 |
Brand name | SOLYSTAT |
Common or Proper name | SOLYSTAT 250mg/mL U.D.SUSP |
Company Name | PENDOPHARM DIVISION OF PHARMASCIENCE INC |
Market Status | MARKETED |
Active Ingredient(s) | SODIUM POLYSTYRENE SULFONATE |
Strength(s) | 250MG |
Dosage form(s) | SUSPENSION |
Route of administration | ORAL |
Packaging size | 60mL |
ATC code | V03AE |
ATC description | ALL OTHER THERAPEUTIC PRODUCTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2017-06-06 |
Actual start date | 2017-06-06 |
Estimated end date | 2017-10-16 |
Actual end date | 2017-10-11 |
Shortage status | Resolved |
Updated date | 2017-10-12 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 6111 ROYALMOUNT AVE MONTREAL, QUEBEC CANADA H4P 2T4 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.